{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:14:12Z","timestamp":1779308052943,"version":"3.51.4"},"reference-count":8,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives<\/jats:title>\n            <jats:p>Serology testing is essential for immunological surveillance in the population. This serosurvey was conducted to ascertain the cumulative population immunity against SARS-CoV-2 among adults in Jammu district and to understand the association of seropositivity with sociodemographic and clinical correlates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>On September 30 and October 1, 2020, a household survey was done in 20 villages\/wards chosen from 10 health blocks in district Jammu, India. Demographic, clinical and exposure information was collected from 2000 adults. Serum samples were screened for IgG antibodies using COVID Kavach MERILISA kit. Tests of association were used to identify risk factors associated with IgG positivity. Crude odds ratio with 95 per cent confidence intervals (CIs) was calculated during univariate analysis followed by logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall adjusted seroprevalence for SARS-CoV-2 was 8.8 per cent (95% CI: 8.78-8.82); it varied from 4.1 per cent in Chauki choura to 16.7 per cent Pallanwalla across 10 blocks in the district. Seropositivity was observed to be comparatively higher in 41-50 and 61-70 yr age groups, among males and in rural areas. Fever, sore throat, cough, dyspnoea, myalgias, anosmia, ageusia, fatigue, seizures, history of exposure, medical consultation, hospitalization and missing work showed significant association with seropositivity on univariate analysis. On logistic regression, only sore throat, myalgia and missing work showed significant adjusted odds of IgG positivity. Extrapolation to adult population suggested that exposure to SARS-CoV-2 was 14.4 times higher than reported cases, translating into Infection fatality rate of 0.08 per cent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions<\/jats:title>\n            <jats:p>Since a major part of population was immunologically naive, all efforts to contain COVID-19 need to be vigorously followed while these baseline results provide an important yardstick to monitor the trends of COVID-19 and guide locally appropriate control strategies in the region.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_4489_20","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:27:13Z","timestamp":1659432433000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India"],"prefix":"10.25259","volume":"155","author":[{"given":"Dinesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalli","family":"Bavoria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Kalotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-24-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/postgradmedj-2020-138386","article-title":"SARS-CoV-2 and the pandemic of COVID-19","volume":"97","author":"Adil","year":"2021","journal-title":"Postgrad Med J"},{"key":"R3-24-20241212","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/ijmr.IJMR_2131_20","article-title":"First confirmed case of COVID-19 infection in India:A case report","volume":"151","author":"Andrews","year":"2020","journal-title":"Indian J Med Res"},{"key":"R9-24-20241212","first-page":"98","article-title":"Simplified general method for cluster \u2013Sample surveys of health in developing countries","volume":"44","author":"Bennets","year":"1991","journal-title":"World Health Stat Q"},{"key":"R13-24-20241212","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP):A population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"R14-24-20241212","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jamainternmed.2020.4130","article-title":"Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020","volume":"180","author":"Havers","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R19-24-20241212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijmr.IJMR_3290_20","article-title":"Prevalence of SARS-CoV-2 infection in India:Findings from the national serosurvey","volume":"152","author":"Murhekar","year":"2020","journal-title":"Indian J Med Res"},{"key":"R21-24-20241212","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"Ng","year":"2020","journal-title":"Science"},{"key":"R22-24-20241212","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2021.02.002","article-title":"Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India","volume":"558","author":"Nayak","year":"2021","journal-title":"Virology"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_4489_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:04:43Z","timestamp":1751497483000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/seroprevalence-of-anti-sars-cov-2-igg-antibodies-among-adults-in-jammu-district-india-a-community-based-study\/"}},"subtitle":["A community-based study"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_4489_20","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}